Novel purification of vitronectin from human plasma by heparin affinity chromatography
- PMID: 2460263
- DOI: 10.1247/csf.13.281
Novel purification of vitronectin from human plasma by heparin affinity chromatography
Abstract
The glycoprotein vitronectin (also called S-protein, serum spreading factor, or epibolin) promotes spreading of a variety of cultured cells, inhibits the cytotoxicity of membrane attack complex C5b-9, and modulates thrombin-antithrombin III activity. We developed a strikingly simple method to purify vitronectin from human plasma by heparin affinity chromatography. Serum was obtained from plasma by adding calcium and then centrifuging. The heparin-binding activity of vitronectin in human serum was activated with 8 M urea. The activated vitronectin specifically bound to heparin-Sepharose in 8 M urea and was eluted with 0.5 M NaCl containing 8 M urea. This procedure resulted in an approximately 250-fold purification of vitronectin with a 15-30% recovery; 3-6 mg of pure vitronectin were obtained from 100 ml human plasma within 2 days. The purified vitronectin preparations promoted spreading of BHK fibroblastic cells on substrates with a half-maximal activity at only 0.1 microgram/ml. This new method is very simple, rapid, inexpensive, and flexible. It could probably be readily scaled up for commercial applications.
Similar articles
-
Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea.Blood. 1988 Sep;72(3):903-12. Blood. 1988. PMID: 2458152
-
Purification of vitronectin.Curr Protoc Cell Biol. 2013 Sep 24;60:10.6.1-10.6.7. doi: 10.1002/0471143030.cb1006s60. Curr Protoc Cell Biol. 2013. PMID: 24510786
-
Vitronectin exists in two structurally and functionally distinct forms in human plasma.Biochim Biophys Acta. 1989 Feb 24;990(2):101-8. doi: 10.1016/s0304-4165(89)80019-4. Biochim Biophys Acta. 1989. PMID: 2465025
-
Heparin-binding properties of human serum spreading factor.J Biol Chem. 1985 Aug 5;260(16):9117-22. J Biol Chem. 1985. PMID: 2410408
-
Purification of plasma protein.Haemostasis. 1988;18 Suppl 1:115-9. doi: 10.1159/000215846. Haemostasis. 1988. PMID: 3280421 Review.
Cited by
-
Detection of vitronectin mRNA in tissues and cells of the mouse.Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9402-6. doi: 10.1073/pnas.88.21.9402. Proc Natl Acad Sci U S A. 1991. PMID: 1719529 Free PMC article.
-
Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases.Neuro Oncol. 2006 Apr;8(2):127-36. doi: 10.1215/15228517-2005-013. Epub 2006 Mar 13. Neuro Oncol. 2006. PMID: 16533879 Free PMC article.
-
Activated vitronectin as a target for anticancer therapy with human antibodies.Cancer Immunol Immunother. 2004 Sep;53(9):799-808. doi: 10.1007/s00262-004-0506-z. Epub 2004 Jun 10. Cancer Immunol Immunother. 2004. PMID: 15197494 Free PMC article.
-
Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.J Exp Med. 2009 Mar 16;206(3):691-705. doi: 10.1084/jem.20081278. Epub 2009 Mar 2. J Exp Med. 2009. PMID: 19255147 Free PMC article.
-
Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels.J Cell Biol. 1993 Sep;122(5):1131-43. doi: 10.1083/jcb.122.5.1131. J Cell Biol. 1993. PMID: 8354696 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical